GI
UTHR icon

GLOBALT Investments’s United Therapeutics UTHR Stock Holding History

GLOBALT Investments’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$379K Hold
700
– – 0.01% 195
2026
Q1 		$415K Sell
700
-175
-20% -$87.2K 0.01% 187
2025
Q4 		$426K Hold
875
– – 0.02% 179
2025
Q3 		$367K Hold
875
– – 0.01% 187
2025
Q2 		$251K Hold
875
– – 0.01% 199
2025
Q1 		$270K Sell
875
-25
-3% -$8.57K 0.01% 194
2024
Q4 		$318K Hold
900
– – 0.01% 191
2024
Q3 		$323K Hold
900
– – 0.01% 191
2024
Q2 		$287K Hold
900
– – 0.01% 196
2024
Q1 		$207K Buy
+900
New +$203K 0.01% 202

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

GLOBALT Investments's UTHR Position: Q2 2026 in Review

GLOBALT Investments held its United Therapeutics (UTHR) position steady in Q2 2026 at 700 shares worth $379K. The position accounts for 0.01% of the portfolio, ranked #195.

GLOBALT Investments first reported a position in UTHR in Q1 2024 and has held it in 10 quarters since. The position peaked at $426K in Q4 2025. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • GLOBALT Investments held 700 shares of United Therapeutics worth $379K as of Q2 2026.
  • GLOBALT Investments left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up 0.01% of GLOBALT Investments's portfolio in Q2 2026, its #195 holding.
  • GLOBALT Investments first reported a position in United Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • GLOBALT Investments's United Therapeutics position peaked at $426K in Q4 2025.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on GLOBALT Investments's 13F filing for Q2 2026, filed 11 Aug 2026.